Patient engagement and advocacy considerations in development and implementation of a multicancer early detection program
Cancer
.
2022 Feb 15:128 Suppl 4:909-917.
doi: 10.1002/cncr.34047.
Authors
Rebekkah M Schear
1
,
Jody M Hoyos
2
,
Anjee Q Davis
3
,
Phylicia L Woods
3
4
,
Sung Poblete
5
,
Robin N Richardson
6
,
Lila J Finney Rutten
7
Affiliations
1
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin, Austin, Texas.
2
Prevent Cancer Foundation, Alexandria, Virginia.
3
American Cancer Society Cancer Action Network, Inc, Washington, District of Columbia.
4
Fight Colorectal Cancer, Springfield, Missouri.
5
Stand Up to Cancer, Los Angeles, California.
6
Livestrong Cancer Institutes at the Dell Medical School, University of Texas at Austin, Austin, Texas.
7
Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota.
PMID:
35133663
DOI:
10.1002/cncr.34047
No abstract available
MeSH terms
Health Policy
Humans
Neoplasms* / diagnosis
Neoplasms* / therapy
Patient Advocacy
Patient Participation*